Thermo Fisher Scientific Aug 12, 2022 Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer Jul 28, 2022 Thermo Fisher Scientific Touts Performance in China, Delivers Strong Core Growth in Q2 Premium Jul 20, 2022 Fisher Healthcare to Distribute Precipio HemeScreen Assays Jul 12, 2022 RADx-Funded Team Develops Genotyping Panels for Monitoring SARS-CoV-2 Variants Premium Jul 11, 2022 Hologic, Thermo Fisher, Accelerate Diagnostics Products Get CE Marks Jul 8, 2022 In Brief This Week: Thermo Fisher Scientific, FDA, Fulgent Genetics, OpGen, More Jun 15, 2022 Thermo Fisher Scientific Receives CE-IVD Mark for NGS Aneuploidy Diagnostic Software Workflows Jun 13, 2022 At ESHG, Thermo Fisher Official Predicts IVDR Will Push Labs to Replace LDTs With Commercial Kits Premium Jun 10, 2022 In Brief This Week: Thermo Fisher Scientific, T2 Biosystems, MeMed, More Jun 9, 2022 FDA Clears Thermo Fisher Scientific Tests to Help Diagnose Systemic Sclerosis, Lupus May 26, 2022 As IVDR Date of Application Arrives in Europe, Challenges to Implementation Remain Premium May 20, 2022 In Brief This Week: BioMérieux, LumiraDx, Chembio Diagnostics, Quanterix, Quest Diagnostics, More May 9, 2022 FDA Classifies Mesa Biotech Recall of Accula SARS-CoV-2 Tests as Class I May 4, 2022 Bio-Techne Fiscal Q3 Revenues Rise 19 Percent Apr 28, 2022 Thermo Fisher Scientific Reports 19 Percent Q1 Revenues Growth, Beating Expectations Apr 6, 2022 As COVID-19 Sales Retreat, Diagnostic Firms Turn Attention to Core Businesses Premium Mar 29, 2022 Thermo Fisher Scientific Obtains CE Mark for Ion Torrent Genexus Dx Integrated Sequencer Feb 25, 2022 Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says Premium Feb 25, 2022 In Brief This Week: Labcorp, QuantuMDx, LumiraDx, Danaher, Thermo Fisher Scientific, and More Feb 22, 2022 Bio-Techne, Thermo Fisher Scientific to Further Develop, Commercialize Kidney Transplant Rejection Assay Load More Breaking News BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option Careviso Closes $17.4M Series B Funding Round P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test BioAffinity Technologies Nabs $15.6M from Public Offering
